Constitutive activation of signal transducers and activators of transcription 3 correlates with cyclin D1 overexpression and may provide a novel prognostic marker in head and neck squamous cell carcinoma - PubMed (original) (raw)
. 2002 Jun 15;62(12):3351-5.
Affiliations
- PMID: 12067972
Constitutive activation of signal transducers and activators of transcription 3 correlates with cyclin D1 overexpression and may provide a novel prognostic marker in head and neck squamous cell carcinoma
Muneyuki Masuda et al. Cancer Res. 2002.
Abstract
The precise mechanism responsible for the frequent overexpression of cyclinD1 in human head and neck squamous cell carcinoma (HNSCC) is not known. In view of the fact that signal transducers and activators of transcription 3 (Stat3) is often activated in HNSCC cells, we examined the effects of Stat3 on cyclin D1 expression and cell proliferation in the YCU-H891 HNSCC cell line that displays constitutive activation of Stat3. Expression of a dominant negative Stat3 construct in YCU-H891 cells inhibited proliferation, cyclin D1 promoter activity, and cellular levels of cyclin D1 mRNA and protein. The levels of the antiapoptotic Bcl-2 and Bcl-X(L) proteins were also inhibited. In 51 primary tumor samples from patients with squamous cell carcinoma of the p.o. tongue, there was a significant correlation between increased levels of the activated form of Stat3, phosphorylated-Stat3, and increased levels of cyclin D1 (P < 0.0001). Increased tumor levels of phosphorylated-Stat3 were also associated with lower survival rates (P < 0.01). This study provides the first evidence that in HNSCC, constitutive activation of Stat3 plays a causative role in overexpression of cyclin D1, and in clinical studies, Stat3 activation may provide a novel prognostic factor. Furthermore, agents that target Stat3 may be useful in the treatment of HNSCC.
Similar articles
- Signal transducers and activators of transcription 3 up-regulates vascular endothelial growth factor production and tumor angiogenesis in head and neck squamous cell carcinoma.
Masuda M, Ruan HY, Ito A, Nakashima T, Toh S, Wakasaki T, Yasumatsu R, Kutratomi Y, Komune S, Weinstein IB. Masuda M, et al. Oral Oncol. 2007 Sep;43(8):785-90. doi: 10.1016/j.oraloncology.2006.10.007. Epub 2006 Dec 13. Oral Oncol. 2007. PMID: 17169602 - Activation of signal transducers and activators of transcription 3 and overexpression of its target gene CyclinD1 in laryngeal carcinomas.
Liu B, Ren Z, Shi Y, Guan C, Pan Z, Zong Z. Liu B, et al. Laryngoscope. 2008 Nov;118(11):1976-80. doi: 10.1097/MLG.0b013e31817fd3fa. Laryngoscope. 2008. PMID: 18758380 - STAT3 activation abrogates growth factor dependence and contributes to head and neck squamous cell carcinoma tumor growth in vivo.
Kijima T, Niwa H, Steinman RA, Drenning SD, Gooding WE, Wentzel AL, Xi S, Grandis JR. Kijima T, et al. Cell Growth Differ. 2002 Aug;13(8):355-62. Cell Growth Differ. 2002. PMID: 12193474 - STAT proteins: novel molecular targets for cancer drug discovery.
Turkson J, Jove R. Turkson J, et al. Oncogene. 2000 Dec 27;19(56):6613-26. doi: 10.1038/sj.onc.1204086. Oncogene. 2000. PMID: 11426647 Review. - STAT signaling in head and neck cancer.
Song JI, Grandis JR. Song JI, et al. Oncogene. 2000 May 15;19(21):2489-95. doi: 10.1038/sj.onc.1203483. Oncogene. 2000. PMID: 10851047 Review.
Cited by
- PI3K and STAT3: a new alliance.
Vogt PK, Hart JR. Vogt PK, et al. Cancer Discov. 2011 Nov;1(6):481-6. doi: 10.1158/2159-8290.CD-11-0218. Cancer Discov. 2011. PMID: 22348200 Free PMC article. Review. - STAT3-Mediated Metabolic Reprograming in Cellular Transformation and Implications for Drug Resistance.
Poli V, Camporeale A. Poli V, et al. Front Oncol. 2015 Jun 8;5:121. doi: 10.3389/fonc.2015.00121. eCollection 2015. Front Oncol. 2015. PMID: 26106584 Free PMC article. Review. - Phosphorylation of signal transducer and activator of transcription 3 (STAT3) correlates with Her-2 status, carbonic anhydrase 9 expression and prognosis in esophageal cancer.
Schoppmann SF, Jesch B, Friedrich J, Jomrich G, Maroske F, Birner P. Schoppmann SF, et al. Clin Exp Metastasis. 2012 Aug;29(6):615-24. doi: 10.1007/s10585-012-9475-3. Epub 2012 Apr 8. Clin Exp Metastasis. 2012. PMID: 22484976 - UM-SCC-104: a new human papillomavirus-16-positive cancer stem cell-containing head and neck squamous cell carcinoma cell line.
Tang AL, Hauff SJ, Owen JH, Graham MP, Czerwinski MJ, Park JJ, Walline H, Papagerakis S, Stoerker J, McHugh JB, Chepeha DB, Bradford CR, Carey TE, Prince ME. Tang AL, et al. Head Neck. 2012 Oct;34(10):1480-91. doi: 10.1002/hed.21962. Epub 2011 Dec 13. Head Neck. 2012. PMID: 22162267 Free PMC article. - Salinomycin induces cell death via inactivation of Stat3 and downregulation of Skp2.
Koo KH, Kim H, Bae YK, Kim K, Park BK, Lee CH, Kim YN. Koo KH, et al. Cell Death Dis. 2013 Jun 27;4(6):e693. doi: 10.1038/cddis.2013.223. Cell Death Dis. 2013. PMID: 23807222 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous